Genetic diversity within Mycobacterium tuberculosis complex impacts on the accuracy of genotypic pyrazinamide drug-susceptibility assay

Claudio U. Köser*, Iñaki Comas, Silke Feuerriegel, Stefan Niemann, Sebastien Gagneux, Sharon J. Peacock

*Corresponding author for this work

    Research output: Contribution to journalLetterpeer-review

    11 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)451-453
    Number of pages3
    Issue number4
    Publication statusPublished - Jul 2014

    Bibliographical note

    Funding Information:
    This publication presents independent research supported by the Health Innovation Challenge Fund (HICF-T5-342 and WT098600), a parallel funding partnership between the Department of Health and Wellcome Trust. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health or Wellcome Trust.

    Funding Information:
    This work was supported by a grant from the Department of Health , Wellcome Trust and the Health Innovation Challenge Fund ( HICF-T5-342 and WT098600 ) and Public Health England (to S.J.P.). C.U.K. is a Junior Research Fellow at Wolfson College, Cambridge. I.C. is supported by the Spanish Government (Ramón y Cajal programme RYC-2012-10627).


    • Mycobacterium tuberculosis complex
    • Phylogenetic diversity
    • Pyrazinamide resistance

    Cite this